{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:31:42Z","timestamp":1793291502704,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Pfizer (Germany)","award":["NCT00473187"],"award-info":[{"award-number":["NCT00473187"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00467-017-3820-3","type":"journal-article","created":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T10:46:31Z","timestamp":1508496391000},"page":"447-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets"],"prefix":"10.1007","volume":"33","author":[{"name":"on Behalf of the Hypophosphatemic Rickets Study Group of the \u201cDeutsche Gesellschaft f\u00fcr Kinderendokrinologie und -diabetologie\u201d and \u201cGesellschaft f\u00fcr P\u00e4diatrische Nephrologie\u201d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Meyerhoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagen","family":"Staude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"W\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Beetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Holder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Billing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Rabl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Hiort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen H.","family":"Br\u00e4mswig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Richter-Unruh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"\u017divi\u010dnjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"issue":"11","key":"3820_CR1","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 87(11):4957\u20134960","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"3820_CR2","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348(17):1656\u20131663","journal-title":"N Engl J Med"},{"issue":"1","key":"3820_CR3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","volume":"107","author":"R Goetz","year":"2010","unstructured":"Goetz R, Nakada Y, MC H, Kurosu H, Wang L, Nakatani T, Shi M, Eliseenkova AV, Razzaque MS, Moe OW, Kuro-o M, Mohammadi M (2010) Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-klotho complex formation. Proc Natl Acad Sci U S A 107(1):407\u2013412","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"3820_CR4","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","volume":"17","author":"S Liu","year":"2006","unstructured":"Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17(5):1305\u20131315","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"3820_CR5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res 26(7):1381\u20131388","journal-title":"J Bone Miner Res"},{"issue":"2","key":"3820_CR6","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00590-014-1496-y","volume":"25","author":"V Pavone","year":"2015","unstructured":"Pavone V, Testa G, Gioitta Iachino S, Evola FR, Avondo S, Sessa G (2015) Hypophosphatemic rickets: etiology, clinical features and treatment. Eur J Orthop Surg Traumatol 25(2):221\u2013226","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"2","key":"3820_CR7","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s00467-010-1705-9","volume":"26","author":"M Zivicnjak","year":"2011","unstructured":"Zivicnjak M, Schnabel D, Billing H, Staude H, Filler G, Querfeld U, Schumacher M, Pyper A, Schroder C, Bramswig J, Haffner D (2011) Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets. Pediatr Nephrol 26(2):2232\u20132231","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"3820_CR8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s004310050962","volume":"157","author":"K Kruse","year":"1998","unstructured":"Kruse K, Hinkel GK, Griefahn B (1998) B calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets. Eur J Pediatr 157(11):894\u2013900","journal-title":"Eur J Pediatr"},{"issue":"8","key":"3820_CR9","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1210\/jc.2003-030036","volume":"88","author":"O Makitie","year":"2003","unstructured":"Makitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88(8):3591\u20133597","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3820_CR10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-011-2046-z","volume":"27","author":"C Quinlan","year":"2012","unstructured":"Quinlan C, Guegan K, Offiah A, Neill RO, Hiorns MP, Ellard S, Bockenhauer D, Hoff WV, Waters AM (2012) Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment. Pediatr Nephrol 27(4):581\u2013588","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3820_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00467-012-2364-9","volume":"28","author":"F Santos","year":"2013","unstructured":"Santos F, Fuente R, Mejia N, Mantecon L, Gil-Pena H, Ordonez FA (2013) Hypophosphatemia and growth. Pediatr Nephrol 28(4):595\u2013603","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3820_CR12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00431-006-0357-z","volume":"166","author":"G Ariceta","year":"2006","unstructured":"Ariceta G, Langman CB (2006) Growth in X-linked hypophosphatemic rickets. Eur J Pediatr 166(4):303\u2013309","journal-title":"Eur J Pediatr"},{"issue":"1","key":"3820_CR13","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","volume":"3","author":"A Linglart","year":"2014","unstructured":"Linglart A, Biosse-Duplan M, Briot K, Chaussain C, Esterle L, Guillaume-Czitrom S, Kamenicky P, Nevoux J, Prie D, Rothenbuhler A, Wicart P, Harvengt P (2014) Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect 3(1):R13\u2013R30","journal-title":"Endocr Connect"},{"issue":"11","key":"3820_CR14","doi-asserted-by":"crossref","first-page":"E352","DOI":"10.1210\/jc.2010-0589","volume":"95","author":"TO Carpenter","year":"2010","unstructured":"Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM (2010) Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab 95(11):E352\u2013E357","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"3820_CR15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/BF03349633","volume":"13","author":"R Lanes","year":"1990","unstructured":"Lanes R, Harrison HE (1990) Growth hormone therapy in a poorly growing child with hypophosphatemic rickets. J Endocrinol Investig 13(10):833\u2013837","journal-title":"J Endocrinol Investig"},{"issue":"10","key":"3820_CR16","first-page":"1165","volume":"145","author":"DM Wilson","year":"1991","unstructured":"Wilson DM, Lee PD, Morris AH, Reiter EO, Gertner JM, Marcus R, Quarmby VE, Rosenfeld RG (1991) Growth hormone therapy in hypophosphatemic rickets. Am J Dis Child 145(10):1165\u20131170","journal-title":"Am J Dis Child"},{"issue":"3","key":"3820_CR17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0022-3476(95)70070-6","volume":"127","author":"G Saggese","year":"1995","unstructured":"Saggese G, Baroncelli GI, Bertelloni S, Perri G (1995) Long-term growth hormone treatment in children with renal hypophosphatemic rickets: effects on growth, mineral metabolism, and bone density. J Pediatr 127(3):395\u2013402","journal-title":"J Pediatr"},{"issue":"8","key":"3820_CR18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF02079060","volume":"1154","author":"D Haffner","year":"1995","unstructured":"Haffner D, Wuhl E, Blum WF, Schaefer F, Mehls O (1995) Disproportionate growth following long-term growth hormone treatment in short children with X-linked hypophosphataemia. Eur J Pediatr 1154(8):610\u2013613","journal-title":"Eur J Pediatr"},{"issue":"5","key":"3820_CR19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s004670050340","volume":"11","author":"GS Reusz","year":"1997","unstructured":"Reusz GS, Miltenyi G, Stubnya G, Szabo A, Horvath C, Byrd DJ, Peter F, Tulassay T (1997) X-linked hypophosphatemia: effects of treatment with recombinant human growth hormone. Pediatr Nephrol 11(5):573\u2013577","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"3820_CR20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1542\/peds.100.5.879","volume":"100","author":"MG Seikaly","year":"1997","unstructured":"Seikaly MG, Brown R, Baum M (1997) The effect of recombinant human growth hormone in children with X-linked hypophosphatemia. Pediatrics 100(5):879\u2013884","journal-title":"Pediatrics"},{"issue":"12","key":"3820_CR21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1210\/jc.2011-0399","volume":"96","author":"M Zivicnjak","year":"2011","unstructured":"Zivicnjak M, Schnabel D, Staude H, Even G, Marx M, Beetz R, Holder M, Billing H, Fischer DC, Rabl W, Schumacher M, Hiort O, Haffner D (2011) Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion. J Clin Metab 96(12):2097\u20132105","journal-title":"J Clin Metab"},{"issue":"2","key":"3820_CR22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1067\/mpd.2001.108955","volume":"138","author":"GI Baroncelli","year":"2001","unstructured":"Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G (2001) Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets. J Pediatr 138(2):236\u2013243","journal-title":"J Pediatr"},{"issue":"6","key":"3820_CR23","doi-asserted-by":"crossref","first-page":"E593","DOI":"10.1542\/peds.113.6.e593","volume":"113","author":"D Haffner","year":"2004","unstructured":"Haffner D, Nissel R, Wuhl E, Mehls O (2004) Effects of growth hormone treatment on body proportions and final height among small children with X-linked hypophosphatemic rickets. Pediatrics 113(6):E593\u2013E596","journal-title":"Pediatrics"},{"key":"3820_CR24","first-page":"467","volume-title":"Ultraschall-diagnostik in P\u00e4diatrie und Kinderchirurgie","author":"PF Hoyer","year":"2004","unstructured":"Hoyer PF (2004) Nephrokalzinose. In: Hofmann V, Deeg KH, Hoyer PF (eds) Ultraschall-diagnostik in P\u00e4diatrie und Kinderchirurgie. Thieme, Stuttgart, pp 467\u2013470"},{"key":"3820_CR25","volume-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"WW Greulich","year":"1959","unstructured":"Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press, Stanford"},{"issue":"2","key":"3820_CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00862587","volume":"2","author":"J Brodehl","year":"1988","unstructured":"Brodehl J, Krause A, Hoyer PF (1988) Assessment of maximal tubular phosphate reabsorption: comparison of direct measurement with the nomogram of Bijvoet. Pediatr Nephrol 2(2):183\u2013189","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"3820_CR27","doi-asserted-by":"crossref","first-page":"E53439","DOI":"10.1371\/journal.pone.0053439","volume":"7","author":"VC Souza De","year":"2012","unstructured":"De Souza VC, Rabilloud M, Cochat P, Selistre L, Hadj-Aissa A, Kassai B, Ranchin B, Berg U, Herthelius M, Dubourg L (2012) Schwartz formula: is one k-coefficient adequate for all children? PLoS One 7(12):E53439","journal-title":"PLoS One"},{"key":"3820_CR28","volume-title":"Practical human biology","author":"JS Weiner","year":"1981","unstructured":"Weiner JS, Lourie JA (1981) Practical human biology. Academic Press, London"},{"issue":"1","key":"3820_CR29","first-page":"321","volume":"27","author":"M Zivicnjak","year":"2003","unstructured":"Zivicnjak M, Narancic NS, Szirovicza L, Franke D, Hrenovic J, Bisof V (2003) Gender-specific growth patterns for stature, sitting height and limbs length in Croatian children and youth (3 to 18 years of age). Coll Antropol 27(1):321\u2013334","journal-title":"Coll Antropol"},{"issue":"3","key":"3820_CR30","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00467-006-0345-6","volume":"22","author":"M Zivicnjak","year":"2007","unstructured":"Zivicnjak M, Franke D, Filler G, Haffner D, Froede K, Nissel R, Haase S, Offner G, Ehrich JH, Querfeld U (2007) Growth impairment shows an age-dependent pattern in boys with chronic kidney disease. Pediatr Nephrol 22(3):420\u2013429","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"3820_CR31","first-page":"419","volume":"32","author":"M Zivicnjak","year":"2008","unstructured":"Zivicnjak M, Smolej Narancic N, Szirovicza L, Franke D, Hrenovic J, Bisof V, Tomas Z, Skaric-Juric T (2008) Gender-specific growth patterns of transversal body dimensions in Croatian children and youth (2 to 18 years of age). Coll Antropol 32(2):419\u2013431","journal-title":"Coll Antropol"},{"key":"3820_CR32","first-page":"193","volume-title":"Human growth and development","author":"L Molinari","year":"1985","unstructured":"Molinari L, Largo RH, Prader A (1985) Target height and secular trend in the Swiss population. In: Borms J, Hauspie R, Sand A, Susanne C, Habbelinck M (eds) Human growth and development. Plenum, New York, pp 193\u2013200"},{"issue":"4","key":"3820_CR33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0022-3476(52)80205-7","volume":"40","author":"N Bayley","year":"1952","unstructured":"Bayley N, Pinneau S (1952) Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 40(4):423\u2013441","journal-title":"J Pediatr"},{"issue":"7","key":"3820_CR34","first-page":"A4874","volume":"61","author":"LH Nielsen","year":"2014","unstructured":"Nielsen LH, Rahbek ET, Beck-Nielsen SS, Christesen HT (2014) Treatment of hypophosphataemic rickets in children remains a challenge. Dan Med J 61(7):A4874","journal-title":"Dan Med J"},{"issue":"4","key":"3820_CR35","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","volume":"95","author":"EA Imel","year":"2010","unstructured":"Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 95(4):1846\u20131850","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3820_CR36","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1530\/EJE-15-1018","volume":"174","author":"A Efthymiadou","year":"2016","unstructured":"Efthymiadou A, Kritikou D, Mantagos S, Chrysis D (2016) The effect of GH treatment on serum FGF23 and klotho in GH-deficient children. Eur J Endocrinol 174(4):473\u2013479","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"3820_CR37","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00467-005-1899-4","volume":"20","author":"A Auron","year":"2005","unstructured":"Auron A, Alon US (2005) Resolution of medullary nephrocalcinosis in children with metabolic bone disorders. Pediatr Nephrol 20(8):1143\u20131145","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 3","key":"3820_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000330159","volume":"76","author":"DB Allen","year":"2011","unstructured":"Allen DB (2011) Safety of growth hormone treatment of children with idiopathic short stature: the US experience. Horm Res Paediatr 76 [Suppl 3]:45\u201347","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"3820_CR39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/MOP.0b013e328362c7a2","volume":"25","author":"PM Wolfgram","year":"2013","unstructured":"Wolfgram PM, Carrel AL, Allen DB (2013) Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome. Curr Opin Pediatr 25(4):509\u2013514","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"3820_CR40","first-page":"447","volume":"47","author":"S Ricotti","year":"2011","unstructured":"Ricotti S, Petrucci L, Carenzio G, Klersy C, Calcaterra V, Larizza D, Dalla Toffola E (2011) Prevalence and incidence of scoliosis in Turner syndrome: a study in 49 girls followed-up for 4 years. Eur J Phys Rehabil Med 47(3):447\u2013453","journal-title":"Eur J Phys Rehabil Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-017-3820-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T06:13:33Z","timestamp":1517811213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-017-3820-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,20]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3820"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3820-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,20]]}}}